Enveric Biosciences, Inc. (ENVB:NASDAQ) closed at $1.44 on November 9, 2026, up 2.13% on the day. The stock trades 89.1% below its 52-week high of $13.25 and 23.1% above its 52-week low of $1.17. Over the past year, it lost 75.8%. Enveric Biosciences, Inc. is part of the Technology sector.
In 252 trading sessions since November 7, 2025, ENVB closed higher on 108 days (43%). Its best day was April 20, 2026 (+100.55%) and its worst was December 11, 2025 (-47.34%). The stock moved 10% or more in a single session 23 times. It opened at least 5% above the previous day's high 2 times.
Enveric Biosciences Inc is a patient-centric biotechnology company focused on developing new-generation, naturally occurring chemical compounds, such as cannabinoids to improve the lives of those who are adversely affected by the side effects of cancer treatments. Its product in the pipeline includes Glioblastoma Multiforme (GBM); Radiation Dermatitis and Chemotherapy-Induced Peripheral Neuropathy (CIPN).
Find more stocks like ENVB with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.